Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Bellerophon Therapeutics stock
Learn how to easily invest in Bellerophon Therapeutics stock.
Bellerophon Therapeutics Inc is a biotechnology business based in the US. Bellerophon Therapeutics shares (BLPH) are listed on the NASDAQ and all prices are listed in US Dollars. Bellerophon Therapeutics employs 20 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in Bellerophon Therapeutics
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – BLPH – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Bellerophon Therapeutics stock price (NASDAQ: BLPH)Use our graph to track the performance of BLPH stocks over time.
Bellerophon Therapeutics shares at a glance
|Latest market close||$1.09|
|52-week range||$0.67 - $4.49|
|50-day moving average||$1.35|
|200-day moving average||$1.78|
|Wall St. target price||$24.50|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-1.89|
Buy Bellerophon Therapeutics shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Bellerophon Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Bellerophon Therapeutics price performance over time
|1 week (2022-09-23)||3.81%|
|1 month (2022-09-01)||-3.54%|
|3 months (2022-07-01)||-6.84%|
|6 months (2022-03-28)||N/A|
|1 year (2021-10-01)||-71.69%|
|2 years (2020-10-01)||-88.99%|
|3 years (2019-10-01)||109.98%|
|5 years (2017-09-29)||1.42|
Bellerophon Therapeutics financials
|Gross profit TTM||$0|
|Return on assets TTM||-48.51%|
|Return on equity TTM||-88.03%|
|Market capitalisation||$10 million|
TTM: trailing 12 months
Bellerophon Therapeutics share dividends
We're not expecting Bellerophon Therapeutics to pay a dividend over the next 12 months.
Have Bellerophon Therapeutics's shares ever split?
Bellerophon Therapeutics's shares were split on a 1:15 basis on 9 February 2020. So if you had owned 15 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Bellerophon Therapeutics shares – just the quantity. However, indirectly, the new 1400% higher share price could have impacted the market appetite for Bellerophon Therapeutics shares which in turn could have impacted Bellerophon Therapeutics's share price.
Bellerophon Therapeutics share price volatility
Over the last 12 months, Bellerophon Therapeutics's shares have ranged in value from as little as $0.67 up to $4.49. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Bellerophon Therapeutics's is -0.0763. This would suggest that Bellerophon Therapeutics's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Bellerophon Therapeutics has bucked the trend.
Bellerophon Therapeutics overview
Bellerophon Therapeutics, Inc. , a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its product includes INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension. The company engages in the development of INOpulse that is in Phase 3 clinical trial for the treatment of pulmonary hypertension associated with fibrotic interstitial lung disease; which has completed Phase 2a clinical trial for pulmonary hypertension associated with chronic obstructive pulmonary disease; and that has completed Phase 2 dose escalation stage for pulmonary hypertension associated with sarcoidosis, as well as for chronic thromboembolic pulmonary hypertension and pulmonary hypertension associated with pulmonary edema from high altitude sickness. The company was formerly known as Ikaria Development LLC and changed its name to Bellerophon Therapeutics, Inc. in January 2014. Bellerophon Therapeutics, Inc.
Bellerophon Therapeutics in the news
Bellerophon (BLPH) Receives FDA Acceptance to Reduce Study Size
Bellerophon Announces FDA Acceptance of Change to Ongoing Phase 3 REBUILD Study of INOpulse® for Treatment of Fibrotic Interstitial Lung Disease
Frequently asked questionsWhat percentage of Bellerophon Therapeutics is owned by insiders or institutions?
Currently 3.518% of Bellerophon Therapeutics shares are held by insiders and 31.761% by institutions. How many people work for Bellerophon Therapeutics?
Latest data suggests 20 work at Bellerophon Therapeutics. When does the fiscal year end for Bellerophon Therapeutics?
Bellerophon Therapeutics's fiscal year ends in December. Where is Bellerophon Therapeutics based?
Bellerophon Therapeutics's address is: 184 Liberty Corner Road, Warren, NJ, United States, 07059 What is Bellerophon Therapeutics's ISIN number?
Bellerophon Therapeutics's international securities identification number is: US0787713009 What is Bellerophon Therapeutics's CUSIP number?
Bellerophon Therapeutics's Committee on Uniform Securities Identification Procedures number is: 078771102
More guides on Finder
How to buy YanGuFang International Group (YGF) stock when it goes public
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
How to buy Lead Real Estate Co. (LRE) stock when it goes public
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
How to buy Third Harmonic Bio (THRD) stock
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
How to buy LINKBANCORP (LNKB) stock
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.
Ask an Expert